Corcept Therapeutics Incorporated.
(NASDAQ : CORT)

( )
CORT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.27%169.660.4%$318.11m
AMRNAmarin Corporation Plc Sponsored ADR
-0.66%16.572.0%$239.83m
JAZZJazz Pharmaceuticals Plc
0.52%140.382.2%$115.51m
PRGOPerrigo Co. Plc
-0.59%58.506.8%$76.64m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.17%122.996.3%$57.96m
MNKMallinckrodt Plc
1.31%20.9521.1%$57.42m
ICLRICON Plc
-0.60%138.224.1%$45.74m
SAGESAGE Therapeutics, Inc.
0.27%107.849.6%$41.83m
UTHRUnited Therapeutics Corporation
1.19%109.7914.4%$40.53m
ENDPEndo International Plc
-1.23%11.218.9%$40.43m
ICPTIntercept Pharmaceuticals, Inc.
-1.32%104.5918.6%$39.92m
HZNPHorizon Pharma plc
0.00%19.567.4%$37.97m
CTLTCatalent Inc
1.67%36.302.4%$36.79m
ZGNXZogenix, Inc.
1.32%43.6510.0%$25.85m
AERIAerie Pharmaceuticals, Inc.
1.20%40.536.9%$25.36m

Company Profile

Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.